Korean Circ J.  1974 Jun;4(1):17-23. 10.4070/kcj.1974.4.1.17.

Experimental Study of Practolol on Cardiac Arrhythmias

• Kim JS

• KMID: 2229708
• DOI: http://doi.org/10.4070/kcj.1974.4.1.17

Abstract

Recently several adrenergic beta receptor blocking agents such as dichloroisoprenaline, pronethalol, INPEA, H13/57, propranolol, sotalol, tolamolol, practolol and butoxamine were reported. It has been postulated for some time that there are two subgroups of beta receptors: cardiac receptors (beta 1-eceptor) and peripheral receptors (beta 2-receptor) responsible for vasodilatation and broncholdilatation. More recently, the cardioselective beta blockers have been developed; for example, practolol, and talamolol. Rabbits were anesthetized by the peritoneal injection of urethane 1 gm/kg and observed for 30 minutes. Arrhythmias were produced with lanatocide-C and norepinephrine through the ear vein of the anesthetized rabbits. Arrhythmias such as premature ventricular contraction and ventricular tachycardia were present within 7 minutes to 20 minutes after the injection of lanatocide-C 0.9mg, and within 15 seconds to 2 minutes after the injection of norepinephrine 150ug. Propranolol or practolol were injected before and after the production of the arrhythmias and so Lead II of the electrocardiogram was obtained from nedle electrodes inserted into the skin. Practolol was compared with propranolol on the changes of the heart rates and the arrhytmias produced by the injection of norepinephrine and lanatocide-C. The intravenous injection of propranolol and practolol reduced the heart rate but practolol reduced much lesser than propranolol. All of arrhythmias produced by lanatocide-C in anesthetzedrabbits were not abolished by practolol, but it blocked and prevented the development of arrhythmias in anesthetized rabbits on the administration of norepinephrine.

MeSH Terms

Arrhythmias, Cardiac*
Butoxamine
Ear
Electrocardiography
Electrodes
Heart Rate
Injections, Intravenous
Norepinephrine
Practolol*
Propranolol
Rabbits
Skin
Sotalol
Tachycardia, Ventricular
Urethane
Vasodilation
Veins
Ventricular Premature Complexes
Butoxamine
Norepinephrine
Practolol
Propranolol
Sotalol
Urethane

Figure

• 

  Fig. 1. The change of the heart rates after the intervenous injuction of practolol and propranolol.

Reference

1.Ahlquist R.P.A study of the adrenotropic receptors. Am. J. Physio. 153:586. 1948.

2.Powell C.E.., Slater I.H.Blocking of adrenergic receptors by a dichloro analog of isoproterenol. J. Pharmac. Exp. Ther. 122:480. 1958.

3.C Black J.W.., Stevenson J.S.Phasiacology of a nezv adrenergic beta-receptcr blocking compound. Lancet. 11:311. 1962.

4.Teotino U.M., et al. Synthesis ci?id pharryiacclogical properties of some derivatives of p-a?ninophenyletha-nclamine. J, Pharmac. 15:26. 1963.

5.Corrodi H., et al. Λ nezv se?-ie3 cf substances zvhich block adrenergic beta-reccptors. J. Med. Chem. 6:751. 1963.

6.Black J.V.., Duncan W.A.M.., Shanks R.G.Ccmparison of some properties of pronethedol and propranolol. Br. J. Pharmac. Chcmcther. 25:577. 1965.

7). Lish P.M.., Weikel J.H.., Duncan K.W.Pharmacological and toxicologic al properties of tzvo nexv beta-adrenergic receptor antagonists. J. Pharmac. Exp, Ther. 149:161. 1965.

8.Shanks R.G., et al. Some pharmacological properties of a nezv adrenergic bet a-receptor antagonist. Nature (Londori). 212:88. 1966.

9). Johns son G., et al. Djur exp erimentellaoch human farmakologiska studier av beta-adremrga receptorblockerare, L akartidn. 63(Suppl):47. 1966.

10). Moran N.C.Pharmacologic ai characterization of adrenergic receptors. Rev. PharmcoL. 18:503. 1966.

11). Lucchesi B.R.The action of nsthalide upon experimentally induced cardiac arrhythmias. J. Pharmac. Exp. Ther. 145:286. 1964.

12). Vaughan Williams E.M.., Sekiya Α.Prevention of arrhythmias due to cardiac glycosides by block of beta sympathetic receptors. Lancet. 1:420. 1963.

13). Payne J. P.., Senfield R.M.Pronethal이in the treatment of ventricular arrhythmias during anesthesia. Bri. M.J. 1:603. 1964.

14). Dunlop D.., Shanks R.G.Selective blockade of adrencceptive beta receptors in the heart‘Brit. J. Pharmacol. 32:201. 1968.

15). Sarnoff S.J.., Brockman S.K.Gilmore, J.P., Linden, R.J. and Mitchell, J.H.: Regulation of ventricular contraction: Influence of cardiac sympathetic and vagal nerve stimulation on atrial and ventricular dynamics. Circ. Res. 8:1108. 1960.

16). Advenier C. Boissier. J.R. and Giudicelli, J.F. Comparative study cf 6-beta adrencceptive antagonists (m ainvay 7. est stance and heart rate in the guinea-pig. Brit. J. Ρ harm. 44:642. 1972.

17). Barrett A.M.., Carter J.Comparative chronotropic activity of beta-adrenoceptive an.tagonist. z5r. J. Pharmac. 40:373. 1970.

18). Moran N.C.., Perkins M.E.An evaluation of adrenergic blockade of the mammalian heart. J. Pharmac. Exp. Ther. 133:192. 1961.

19). Somani P.., Lum B.K.B.The antiarrhythmic action of beta-adrenergic blocking agents. J. Pharm. Exp. Ther. 147:194. 1965.

20). Shinebourne E.White, R. and Hmaer, J.: A qualitative distinction between the beta-receptor blocking and local anesthetic actions of antiarrhythmic agents, dr. Res. 24:835. 1969.

21). Lucchesi B.R.The effects of pronethal이and its dextrcisomer upon experimental cardiac arrhythmias. J. Pharmac. Exp. Ther. 148:9. 1965.

22). Shanks R.G.., DunlOp D.The effect of propranolol and arrhythmias follozcing coronary artery occlusion in dogs. Cardiovasca. Res. 134:1967.

23). Barrett A.M.., Crowther A.F.., Dunlop D.., Shanks R.G.., Smith L.H.Cardioselective beta blockade. Arch. Exper. Path, u, Pharmacol. 259:152.

24). Madan B.R.., Soni R.K.Effect of beta-adrenoceptor blocking agents on poststimulatory atrial flutter in the dog, with observation on the participaticn of adrenergic mechanisms in this experimental arrhythmia. Br. J. Pharmac. 44:109. 1972.

25). Dollery C.T.Paterson, J.W. & Conolly, M.E.: Clinical pharmacology of beta-receptor blocking drugs. Clin. Pharmac. Τ her. 10:765. 1969.

26). Gibson B.., Balcon R.., Sowton E.The clinical use of ICI 50172 as an antidysrhythmic agents in patients with heart failure. Br. MecL J. 3:161. 1968. ,.

27). Howe R.., Shanks R.G.Optical isomers of propranolol. Nature. 210:1366. 1966.

28). Theilen E.O.., Wilson W.R.Beta adrenergic blocking agents and cardiac arrhythmias. M. Clin. North America. 52:1017. 1968.

29). Turner J.R.B.Propranolol in the treatment of digitalis induced and digitalis-resistant tachycardia. Am. J. Cardiol. 18:450. 1966.

30). Stock J.P. P.Beta-adrenergic blocking drugs in the clinical management of cardiac arrhythmias. Am. J. Cardiol. 18:444. 1966.

31). Barrett A.M.., Cullurn V.A.The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Brit. J. Pharmacol. 34:43. 1968.